AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance
Diabetes continues to be the leading cause of new cases of blindness among adults in the United States. But the current shortage of eye-care providers would make it impossible to keep up with demand to provide the requisite annual screenings for this population. A new study looks at the effectiveness of seven artificial intelligence-based screening algorithms to diagnose diabetic retinopathy, the most common diabetic eye disease leading to vision loss.
In a paper published Jan. 5 in
Diabetes Care, researchers compared the algorithms against the diagnostic expertise of retina specialists. Five companies produced the tested algorithms - two in the United States (Eyenuk, Retina-AI Health), one in China (Airdoc), one in Portugal (Retmarker), and one in France (OphtAI).
河西走廊的鼓楼 _发现之旅_中国甘肃网
gscn.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gscn.com.cn Daily Mail and Mail on Sunday newspapers.
Trabzonspor un Göztepe karşısındaki kozu Ekuban
61saat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 61saat.com Daily Mail and Mail on Sunday newspapers.